Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 142.55
-2.50 (-1.72%)
At close: Jan 19, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 6.32 billion as of January 23, 2026. Its market cap has decreased by -37.24% in one year.
Market Cap
6.32B
Enterprise Value
7.52B
Revenue
6.19B
Ranking
n/a
PE Ratio
38.31
Stock Price
142.55
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 6.32B, an increase of 1,004.58%. That is a compound annual growth rate of 10.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 6.32B | -12.71% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 9.64B |
| Lincoln Pharmaceuticals | 9.24B |
| Bharat Parenterals | 7.71B |
| Anuh Pharma | 7.34B |
| Fredun Pharmaceuticals | 7.11B |
| Wanbury | 6.93B |
| Accent Microcell | 6.78B |
| Kilitch Drugs (India) | 5.40B |